Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04795765
Other study ID # SISSJS2019US
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date August 19, 2019
Est. completion date December 2024

Study information

Verified date January 2024
Source Stryker Instruments
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This postmarket registry is intended to prospectively collect real world data to support ongoing safety and performance of the SpineJack system.


Description:

The SpineJack System Registry will employ a prospective, multicenter, observational, consecutive enrollment design. The sample size for this Registry will include at least 400 patients treated for VCFs across approximately 10 sites. A total of 240 patients will be treated with the SpineJack system and 160 patients will be treated with other vertebral augmentation (VA) procedures, such as BKP or VP. Sites within the U.S. may include healthcare professionals (HCPs) that are surgeons, pain physicians and/or interventional radiologists.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 400
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. 18 years of age or older 2. Understand and sign the informed consent form (as applicable) 3. Exhibit no altered mental status or language barrier that may prevent completion of the patient reported outcome (PRO) surveys following the procedure. 4. VCF diagnosis made and/or confirmed at participating site. Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
SpineJack system
For use in the reduction of painful osteoporotic vertebral compression fractures.
Balloon kyphoplasty
Treatment of osteoporotic vertebral compression fractures.
Vertebroplasty
Treatment of osteoporotic vertebral compression fractures.

Locations

Country Name City State
United States St. Luke's IntermountainResearch Center Boise Idaho
United States Montefiore Medical Center Bronx New York
United States Clinical Investigations Edmond Oklahoma
United States San Diego Neurosurgery Encinitas California
United States California Orthopedics and Spine Larkspur California
United States Dartmouth Hitchcock Lebanon New Hampshire
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Icahn School of Medicine at Mount Sinai New York New York
United States Center for Diagnostic Imaging (CDI) Puyallup Washington
United States Rainier Orthopedic Institute Puyallup Washington
United States Cleveland Clinic Stuart Florida
United States Wake Forest Baptist Health Winston-Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Stryker Instruments Talosix

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Back pain The numeric rating scale consists of an eleven-point scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable). 12 months post-procedure
Primary Radiological outcomes Vertebral body height restoration Immeditely post-procedure
Primary Radiological outcomes Adjacent level fractures Immediately post-procedure
Primary Adverse events Incidence of adverse device effects (ADEs) and serious adverse device effects (SADEs) requiring surgical re-intervention or re-treatment at the treated level
Incidence of unanticipated ADEs
Incidence of procedure-related AEs
12 months post-procedure
Primary Quality of life indices - Roland Morris Disability Questionnaire (RMDQ) 24-item self-report questionnaire used in patients with mild to moderate disability due to acute, sub-acute or chronic low back pain 12 months post-procedure
Primary Patient-Reported Outcomes Measurement Information System (PROMIS Global-10) 10-item questionnaire that is used to assess general domains of health and functioning, including overall physical health, mental health, social health, pain, fatigue and overall perceived quality of life 12 months post-procedure
See also
  Status Clinical Trial Phase
Completed NCT01482793 - A Controlled Trial of Vertebroplasty for Acute Painful Osteoporotic Fractures N/A
Recruiting NCT01609712 - Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation N/A
Completed NCT00279877 - Cost Effectiveness and Efficacy of Kyphoplasty and Vertebroplasty Trial Phase 3
Recruiting NCT05337696 - Circumferential Vertebral Reconstruction of Osteoporotic Compression Fractures Using a Novel Bipedicular Peek Implant N/A
Recruiting NCT06261242 - Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures Treatment N/A
Recruiting NCT06270173 - Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures N/A